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Abstract
Background: Chatbots and virtual voice assistants are increasingly common in primary care without sufficient evidence for
their feasibility and effectiveness. We aimed to assess how perceived stigma and severity of various health issues are asso-
ciated with the acceptability for three sources of health information and consultation: an automated chatbot, a General
Practitioner (GP), or a combination of both.
Methods: Between May and June 2019, we conducted an online study, advertised via Facebook, for UK citizens. It was a
factorial simulation experiment with three within-subject factors (perceived health issue stigma, severity, and consultation
source) and six between-subject covariates. Acceptability rating for each consultation source was the dependant variable. A
single mixed-model ANOVA was performed.
Results: Amongst 237 participants (65% aged over 45 years old, 73% women), GP consultations were seen as most accept-
able, followed by GP-chatbot service. Chatbots were seen least acceptable as a consultation source for severe health issues,
while the acceptability was significantly higher for stigmatised health issues. No associations between participants’ charac-
teristics and acceptability were found.
Conclusions: Although healthcare professionals are perceived as the most desired sources of health information, chatbots
may be useful for sensitive health issues in which disclosure of personal information is challenging. However, chatbots
are less acceptable for health issues of higher severity and should not be recommended for use within that context.
Policymakers and digital service designers need to recognise the limitations of health chatbots. Future research should
establish a set of health topics most suitable for chatbot-led interventions and primary healthcare services.
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Introduction
Primary healthcare is adopting alternative modes of deliv-
ery to address the growing demand for high-quality ser-
vices, transitioning towards telemedicine and behaviour
modification.1 This shift has been accelerated by the
COVID-19 pandemic and subsequent social distancing
measures facilitating digital innovation to shield vulnerable
patients from being exposed to the infection.2–3
Conversational agents, chatbots or virtual assistants, are a
type of digital technology underpinned by artificial
intelligence (AI) or machine learning, designed to simulate
human-to-human conversation via text or speech, able to
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understand health queries and provide a specific response in
a conversational manner.4–5 One example is the Babylon
“GP at Hand” service which incorporates chatbot function-
ality to triage patient’s health issues and direct them to rele-
vant modes of care.6 The comparison of the diagnoses by
doctors and the ‘GP at Hand’ service showed that the
chatbot was able to diagnose the conditions with similar
accuracy to human doctors.7 Thus, chatbots have the
ability to communicate health information to patients
aiding the less complex task within primary care.
Research into the acceptability of chatbots as consult-
ation source is limited, with a distinct lack of experimental
studies. Similar technologies, such as symptom checkers
have been found to be acceptable to patients and staff in
the primary healthcare context.8 Service users are willing
to accept chatbots for disease diagnosis, given that they
were not substituted for existing healthcare services.9–10
Chatbot acceptability is influenced by a person’s effort
expectancy of using a chatbot, facilitating conditions,
social influences, price value, habit, compatibility and per-
ceived access to the healthcare system.10 The quality of the
chatbot content, the perceived accuracy of health informa-
tion, and the sources underpinning the chatbot are asso-
ciated with acceptability. Their acceptability is low due to
perceived chatbot responsibility, liability,11–13 perceived
chatbot competence.5,10,11 Patient safety has also been iden-
tified as an important factor associated with acceptability.11
Low acceptability of chatbots, despite proven effectiveness,
would lead to suboptimal uptake of this intervention.
However, research indicates that people are more willing
to disclose sensitive health information to chatbots in com-
parison to health professionals.14–15 Chatbot acceptability
might be higher for stigmatised health issues as they offer
greater anonymity than a face-to-face GP consultation.11
There is a need to establish how this novel technology
can be best utilised within healthcare settings. Fadhil
(2018) suggested that a GP-chatbot combination may
increase chatbots acceptability and facilitate better patient-
doctor communication, however, this mode of healthcare
delivery has not been previously examined.16 As such, we
aimed to assess how perceived stigma and severity are asso-
ciated with chatbot acceptability by comparing that with
acceptability for chatbot-led, GP-led and GP-chatbot com-
bined consultation sources. The finding would inform the




This study was an online factorial experiment design which
included three within-subject factors (the stigma and the
severity of the health issue and the consultation source)
and six between-subject covariates (prior chatbot
knowledge, confidence of chatbot knowledge, average
internet usage, age, gender and education level). The
outcome variable was participant rated acceptability of
each consultation source. The study protocol and analysis
plan were pre-registered (https://osf.io/szgma/). Approval
was granted by the ethics committee of University
College London (ref:14917/001).
Participants and recruitment
The population of interest was any adult who might at some
point have access to a chatbot for a health-related consult-
ation. For cost and practical reasons, the study was con-
ducted online using paid Facebook advertisement. All
individuals aged 18 years and above with access to the
internet, living in the UK were invited to participate.
These inclusion criteria were reflected in the Facebook
advertisement strategy, which cost £500 in total.
Facebook users that fall into these criteria were shown
with the study advert on their feed and were able to
decide whether to take part in the study. It was unspecified
how Facebook algorithm selected users to display its
adverts and the researchers had little control over the sam-
pling method. The target sample size was 250 participants,
identified as an appropriate range for sufficient statistical
power. No formal power calculations were made as the
effect size was unknown.
Between May 2019 to June 2019, Facebook users were
shown a digital advert inviting them to complete an online
survey by clicking on an URL link, with an incentive of a
10 pence donation to a charity upon study completion.
The advert asked if people could spare 10 min to fill out
an online survey about attitudes towards the use of AI in
healthcare. Once participants had accessed the online
survey, they were presented with the information page
and asked to consent.
Measurements
In total, the survey consisted of seven items. First, partici-
pants were asked about the knowledge of chatbots. They
were then presented with a video and text transcript describ-
ing the chatbot technology and its use in healthcare services
and asked to rate their confidence in understanding the
concept of a health chatbot. Later, they were presented
with the 12 health issues such as ‘you have been feeling
severely depressed, and having suicidal thoughts’, ‘you
have what you think are headlice’ and ‘you have been
coughing up blood’ (see supplementary file A) and asked
to indicate the most preferred and acceptable consultation
source. In the end, participants were asked demographic
questions such as age, gender, educational attainment and
internet usage.17–18
The outcome measure, acceptability of each consultation
source, was based on the Acceptability Framework19 and
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was operationalised as a proxy measure ‘willingness’.
Participants were presented with the statement ‘I would
be willing to use this option to find out what is wrong
and recommend treatment’ and were asked to rate their
willingness to use each of the three consultation sources
on a 5-point Likert scale (ranging from 1= ‘not very
willing at all’; to 5= ‘very willing’) for each presented
health issue. Scores under three were interpreted as a less
acceptable rating by participants, while scores over three
were interpreted as a more acceptable rating by participants.
The three experimental factors were: health issue stigma
(more/less), health issue severity (high/low) and iii) con-
sultation source (chatbot, GP, GP-chatbot combination).
This resulted in 12 conditions (see supplementary file B).
The participants were randomly presented with three
health issues for each more/less stigmatised or high/low
severity condition to balance participant fatigue and prac-
tice effects. Each participant was asked to rate their accept-
ability of each of the three consultation sources for each
consultation source. Participants were asked to complete
36 acceptability ratings and were blinded to the predicted
stigma or severity of the health issue. This was to ensure
that the participants retained their interpretation of the
stigma and severity of the health issue.
Data analyses
The means (M ) and standard errors (SE) of acceptability
ratings for chatbot, GP and GP-chatbot combination were
calculated for all categories of participants where compari-
sons were being made. Both research questions were
addressed together in a single mixed-model analysis of var-
iance. The model included all main effects and all 2-way
interactions involving consultation source. It also included
the 3-way interaction between apparent stigma, severity
and consultation source.
Results
A total of 237 participants completed the study (Table 1).
The majority were female (73.4%), aged over 45 years
old (65.0%), and educated with a degree or higher
(54.9%). Most had no prior knowledge of chatbots
(59.5%) but were confident in their understanding of the
technology once the concept was explained (70.9%).
A significant main effect for consultation source
(Table 2) F(2, 372)= 33.85, p < .001, partial η2= 0.15
was found. GPs were reported as the most acceptable con-
sultation source (M= 3.96, SE= 0.08), followed by a
GP-chatbot combination (M= 3.43, SE= 0.11) and chat-
bots alone (M= 3.08, SE= 0.11). There was a significant
interaction between acceptability and severity F(2, 372)
= 118.14, p < .001, partialη2= 0.38, with GPs (M= 4.42,
SE= 0.06), and a GP-chatbot combination (M= 3.44, SE
= 0.12) being most acceptable for high severity health
issues while chatbots least acceptable (M= 2.68, SE=
0.12). For low severity health issues, GPs were most
acceptable (M= 3.51, SE= 0.11), followed by chatbots








Male 51 (21.5) 3.61 (0.12)
Female 174 (73.4) 3.38 (0.08)
Missing 12 (5.1)
Age
18–44 76 (32.1) 3.49 (0.12)
45+ 154 (65) 3.50 (0.09)
Missing 7 (3)
Educational level
Anything else 99 (41.8) 3.38 (0.10)
Degree and above 130 (54.9) 3.60 (0.09)
Missing 8 (3.4)
Prior knowledge
No 141 (59.5) 3.57 (0.10)




Low confidence 68 (29.1) 3.42 (0.13)
High confidence 168 (70.9) 3.56 (0.74)
Missing 0 (0)
Internet use
Low usage 111 (46.8) 3.54 (0.10)
High usage 118 (49.8) 3.44 (0.09)
Missing 8 (3.4)
Note: SEM= Standard Error of the Mean.
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Rating (SEM) F(df) p-value
Consultation source GP 3.96 (0.08) 33.85(2, 372) <0.001
GP-Chatbot 3.43 (0.11)
Chatbot 3.08 (0.110
Perceived severity by Consultation source
(interaction)





Low severity GP 3.51 (0.11)
GP-Chatbot 3.43 (0.11)
Chatbot 3.48 (0.12)
Perceived stigma by Consultation source
(interaction)





Low stigma GP 4.08 (0.08)
GP-Chatbot 3.45 (0.12)
Chatbot 3.02 (0.11)
Severity by Stigma by Consultation source
(interaction)
High severity & High
stigma


















alone (M= 3.48, SE= 0.12), and GP-chatbot combination
(M= 3.43, SE= 0.11). There was a significant interaction
between acceptability and stigma F(2, 372)= 12.99, p <
.001, partial η= 0.65, with GPs (M= 3.85, SE= 0.08),
being most acceptable for high stigma health issues
while a GP-chatbot combination (M= 3.42, SE= 0.11),
chatbots alone (M= 3.14, SE= 0.12) showed moderate
acceptability. For low stigma health issues, GPs (M=
4.08, SE= 0.08) were reported as the most acceptable con-
sultation source, followed by the GP-chatbot combination
(M= 3.45, SE= 0.12), and a chatbot alone (M= 3.02, SE
= 0.11).
There was a significant interaction between stigma,
severity of the health issue and the acceptability of the con-
sultation sources (Table 2) F(2, 372)= 16.47, p < .001,
partial η2= 0.081. GPs (M= 4.20, SE= 0.08) and
GP-chatbot combination (M= 3.44, SE= 0.12) were
found to be acceptable consultation sources for high
stigma/high severity health issues, while chatbots (M=
2.85, SE= 0.13) were perceived as unacceptable consult-
ation sources. For low stigma/high severity health issues,
GPs (M= 4.65, SE= 0.05) and GP-chatbot combination
(M= 3.43, SE= 0.13) were seen acceptable, while chatbots
(M= 2.51, SE= 0.13) were perceived as unacceptable con-
sultation sources. For high stigma/low severity health
issues, GPs (M= 3.51, SE= 0.11), chatbots (M= 3.44, SE
= 0.13), and a GP-chatbot combination (M= 3.41, SE=
0.12) were comparably seen as acceptable consultation
sources. For low stigma/low severity health issues, chatbots
alone were rated as the most acceptable consultation source
(M= 3.52, SE= 0.13), followed by GPs (M= 3.51, SE=
0.13), and a GP-chatbot combination (M= 3.46, SE= 0.13).
With the between-subject factors, there was insufficient
evidence to conclude that any of the factors influenced
the acceptability ratings by participants (Table 1). There
were non-significant main effects for: age F(1, 186)=
0.002, p= 0.97, partial η2= 0.000; gender F(1, 186)=
2.97, p= 0.09, partial η2= 0.016; educational level F(1,
186)= 3.64, p= 0.06, partial η2= 0.019; prior chatbot
experience F(1, 186)= 1.35, p= 0.25, partial η2= 0.007;
confidence in chatbot understanding F(1, 186)= 1.07, p=
0.3, partial η2= 0.006; and time spent on the internet F(1,
186)= 0.82, p= 0.37, partial η2= 0.004.
Discussion
As far as we know, this is the first study to assess the asso-
ciations between health chatbot acceptability and perceived
stigma/severity of various health conditions. It demon-
strated that in comparison to chatbots participants perceived
health professionals as the most suitable source of health
information. Chatbots were perceived as an unacceptable
intervention for discussion health conditions that were per-
ceived as severe. Therefore, this technology as a
stand-alone intervention may not be utilised by healthcare
customers and should not be used as a substitute for credit-
able health information source from a health professional.
However, chatbots could be considered as an aid for doctor-
patient communication for conditions with lower perceived
stigma and severity. Future research needs to define the
range of these conditions and identify how chatbots may
facilitate greater disclosure of sensitive information to
health professionals who may then be better equipped to
recommend the most relevant healthcare services.
Strengths and limitations
The study had several limitations. As it was advertised
online via popular social media, the participants were
more likely to be digitally literate and have access to tech-
nologies that would enable them to use chatbots. Thus, the
views explored in the study may not reflect individuals with
limited access to technology. The sample was highly
skewed towards middle-aged female participants, which
may reflect the majority of Facebook users in the UK at
that time. Although Facebook advertising is considered a
cost-effective and swift method for study recruitments,
the participants are self-referred and may already hold
strong views on the researched subject compromising the
representativeness and applicability of the findings. The
was also a significant percentage of missing data having
an impact on the validity of the study. It is not clear why
some questions were left unanswered, but this could be
due to participants having a poor understanding of chatbots
and not willing to respond to highly hypothetical questions.
Furthermore, ‘willingness to use chatbot’ may not be the
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Note: SEM= Standard Error of the Mean, df= degrees of freedom.
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ability to predict motivation towards this technology. Other
measures such as intentions or perceived likelihood to use
chatbots could produce different results. To increase the
representativeness or validity of the findings, future
studies should consider offering survey alongside a health
chatbot used in primary care, so that users can interact
with the technology and provide more meaningful
responses about their potential uptake and engagement.
As a simulation study, the conditions participants under-
took were hypothetical, and the willingness to use chatbots
may be different if participants experienced these condi-
tions. Perceptions of severity and stigma may vary, hence
the chatbot acceptability could be dependent on health
beliefs. Patient groups for specific health conditions may
be more or less reluctant to using chatbots. For example,
this technology could be appealing to young adults at risk
of sexually transmitted infections where disclosure of inti-
mate information is challenging. However, chatbots may
not be suitable for those suffering from psychotic episodes
who require support and human care. Although none of the
demographic characteristics was associated with chatbot
acceptability in our study, future research should explore
whether there are specific patient groups receptive to receiv-
ing health education through this technology.
These results build on existing evidence on chatbot
acceptability in healthcare and triangulate the findings of
the existing qualitative research into healthcare chatbot
acceptability.9–10,20 The lower chatbot acceptability could
be due to the lack of familiarity with the technology and
hesitancy towards AI due to poor understanding of auto-
mated healthcare services. Only 70% of participants were
confident in their understanding of chatbots after being
given informational material explaining the functions and
uses of health chatbots, suggesting that the concept of a
computer service mimicking human responses may be dif-
ficult to comprehend. Previous studies also identified mod-
erate acceptability of health chatbots, indicating ‘AI
hesitancy’ in the healthcare context.10 There is a common
misunderstanding that AI drives the function of chatbots.
Chatbots can be complex and driven by AI through
natural language processing. However, most chatbots are
rule-based, i.e. if question A appears, response B should
follow, thus more successful when the query is straightfor-
ward. Users may overestimate the capabilities of chatbots
and be hesitant to use them due to the perception that chat-
bots could in the future replace healthcare professionals.
The lack of empathy from chatbots was seen as a major
barrier to acceptability explaining the preferences for a
human role in the type of health consultation. This was
also reflected in higher acceptability for GP-chatbot com-
bined consultation as opposed to chatbot alone demonstrat-
ing the potential use of this technology. It is also possible
that lower chatbots acceptability, particularly in the UK,
is associated with a lack of perceived need for such innova-
tion a perception that chatbots could influence the access to
health professionals.12 There is a general reluctance
towards new technologies in healthcare, and future devel-
opments of chatbots and voice assistants may influence
their acceptability and engagement.
Future theoretical development needs to consider how
specific health issues influence the acceptability of chatbots
for disease diagnosis. For example, the decision to accept a
chatbot for diagnosis may be influenced by factors such as
the urgency for diagnosis, the person’s wellbeing and how
the individual feels about their symptoms. Future research
should investigate whether user perceptions of usability
differ according to countries and regions. Furthermore, it
is vital to assess how various beliefs about particular dis-
eases affect acceptability and engagement with medical
chatbots. More comprehensive models of chatbot accept-
ability and engagement in healthcare can facilitate the
understanding of their usefulness and applicability.
In conclusion, at present chatbots are not perceived as a
desirable health intervention, and more research is needed
to identify the level of interaction that is most acceptable
to patients. Primary care services could consider chatbots
as a signposting tool aiding health professional or improv-
ing doctor-patient communication for low severity condi-
tions. Future studies need to explore whether chatbots
could facilitate disclosure of sensitive information within
the healthcare context; however, perceived confidentiality,
privacy and security of the technology need to be
ensured. Chatbot-led intervention and service developers
need to be aware of moderate acceptability of this technol-
ogy, taking into account digital literacy and access for the
users.
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